Continuous glucose monitor (CGM)
Continuous glucose monitor (CGM) is a device for people with diabetes that provides continuous "real-time" readings and data about trends in glucose levels. This can allow people with diabetes to understand the level of their glucose and whether it is rising or falling, and to intervene by eating food or taking insulin to prevent it from going too high or too low. To date, continuous glucose monitors from three companies have been approved by the FDA, and a major clinical trial funded by JDRF has found that people with type 1 diabetes who use CGM experience significant improvements in blood sugar control.
Additional information:
- Results of JDRF's CGM Human Clinical Trial published in the New England Journal of Medicine and Diabetes Care
- Join JDRF's CGM Coverage Campaign
- Read JDRF's Position Statement on CGM Coverage by Health Insurers
- Read an article about CGM in the American Association of Clinical Endocrinology publication, First Messenger.
- JDRF CGM Trial Named One of Top Medical Breakthroughs of 2008
For more information about specific continuous glucose monitoring (CGM) devices, click on the links below:
